Nathalie Janel
Janel, Nathalie, 19..-....
Janel, Nathalie
VIAF ID: 173701437 (Personal)
Permalink: http://viaf.org/viaf/173701437
Preferred Forms
- 100 1 _ ‡a JANEL, NATHALIE,
- 100 1 _ ‡a Janel, Nathalie
- 100 1 _ ‡a Janel, Nathalie, ‡d 19..-....
- 100 0 _ ‡a Nathalie Janel
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
1-C metabolism : pathophysiology beyond folate. | |
Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells | |
BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from Down syndrome patients | |
Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis | |
Development and characterization of animal models for polycystic kidney disease and Alzheimer’s disease. | |
Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity | |
Développement et caractérisation de modèles animaux de la maladie d'Alzheimer et de la polykystose rénale | |
Dyrk1a activates antioxidant NQO1 expression through an ERK1/2-Nrf2 dependent mechanism. | |
DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome. | |
Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass | |
Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance. | |
DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels. | |
Early reduction of circulating homocysteine levels in Goto–Kakizaki rat, a spontaneous nonobese model of type 2 diabetes | |
Effect of catechin/epicatechin dietary intake on endothelial dysfunction biomarkers and proinflammatory cytokines in aorta of hyperhomocysteinemic mice | |
Effect of lyophilized prune extract on hyperhomocysteinemia in mice. | |
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans | |
Ethanol-Induced Changes in Brain of Transgenic Mice Overexpressing DYRK1A | |
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage. | |
Exploration de nouveaux paradigmes de régulation de la traduction chez les eucaryotes. | |
Exploring new paradigms of translational control in eukaryotes | |
Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. | |
Hepatoprotective effects of lycopene on liver enzymes involved in methionine and xenobiotic metabolism in hyperhomocysteinemic rats | |
A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase. | |
Hypercholesterolaemia, signs of islet microangiopathy and altered angiogenesis precede onset of type 2 diabetes in the Goto–Kakizaki (GK) rat | |
Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition. | |
Impact of Dyrk1A level on alcohol metabolism. | |
Implication of GSK3β in Islet Inflammation During Diabetes | |
Involvements of DYRK1A protein in Alzheimer’s pathology and development of therapeutic strategies. | |
The iron component of particulate matter is antiapoptotic: A clue to the development of lung cancer after exposure to atmospheric pollutants? | |
Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat | |
The localization of the von Willebrand factor gene on cattle, sheep and goat chromosomes illustrates karyotype evolution in mammals | |
LPS-Induced Inflammation Abolishes the Effect of DYRK1A on IkB Stability in the Brain of Mice. | |
Mechanisms implied in the chronic inflammation and the steatosis observed in the liver of hyperhomocysteinemic mice. | |
Métabolisme des monocarbones. Exploration des mécanismes physiopathologiques au-delà des folates. | |
Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway | |
Mice lacking cystathionine beta synthase have lung fibrosis and air space enlargement | |
Molecular rescue of DYRK1A overexpression in cystathionine beta synthase-deficient mouse brain by enriched environment combined with voluntary exercise. | |
The neuronal SAPK/JNK pathway is altered in a murine model of hyperhomocysteinemia | |
Oct-1 is involved in the transcriptional repression of the von willebrand factor gene promoter. | |
Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues. | |
Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver. | |
Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models. | |
Plasma DYRK1A as a novel risk factor for Alzheimer's disease. | |
Plasma homocysteine levels are not increased in murine models of Alzheimer's disease | |
Plasma nitrate levels are increased in adult Down syndrome patients | |
Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. | |
Primary structure of the propeptide and factor VIII-binding domain of bovine von Willebrand factor. | |
Protection and reversal of hepatic fibrosis by red wine polyphenols in hyperhomocysteinemic mice. | |
Recherches de biomarqueurs impliqués dans la maladie d'Alzheimer et associés à la protéine DYRK1A dans le syndrome de Down pour valider des traitements potentiels | |
Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus | |
Research of biomarkers involved in Alzheimer’s disease and associated with DYRK1A in Down syndrome to validate potential treatments. | |
Rôle de la voie de signalisation de Notch3 dans le myocarde adulte | |
Role of Notch3 signaling pathway in the adult myocardium. | |
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. | |
Search of therapeutic mechanisms in a murine model of hyperhomocysteinemia : food and genetic approach. | |
Silver nanoparticle array structures that produce remarkably narrow plasmon lineshapes | |
Thiol compounds metabolism in mice, rats and humans: Comparative study and potential explanation of rodents protection against vascular diseases | |
Validation of DYRK1A kinase inhibitors optimized to improve cognitive abilities in rodent models of Down syndrome. |